TSW
MD icon

Thompson Siegel & Walmsley’s Pediatrix Medical MD Stock Holding History

Thompson Siegel & Walmsley’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-241,813
Closed -$6.1M – 751
2019
Q2 		$6.1M Sell
241,813
-67,215
-22% -$1.81M 0.09% 159
2019
Q1 		$8.4M Buy
309,028
+78,005
+34% +$2.62M 0.12% 141
2018
Q4 		$7.62M Sell
231,023
-100,012
-30% -$4.02M 0.12% 137
2018
Q3 		$15.4M Sell
331,035
-1,411,921
-81% -$64.8M 0.2% 115
2018
Q2 		$75.4M Sell
1,742,956
-53,336
-3% -$2.56M 0.98% 38
2018
Q1 		$99.9M Sell
1,796,292
-499,910
-22% -$27.4M 1.23% 20
2017
Q4 		$123M Sell
2,296,202
-302,723
-12% -$14.3M 1.46% 10
2017
Q3 		$112M Buy
2,598,925
+428,184
+20% +$20.3M 1.34% 11
2017
Q2 		$131M Buy
2,170,741
+1,062,584
+96% +$63M 1.55% 6
2017
Q1 		$76.9M Buy
1,108,157
+82,351
+8% +$5.72M 0.9% 28
2016
Q4 		$68.4M Buy
1,025,806
+431,881
+73% +$28.1M 0.9% 31
2016
Q3 		$39.3M Sell
593,925
-14,532
-2% -$994K 0.61% 55
2016
Q2 		$44.1M Sell
608,457
-23,857
-4% -$1.64M 0.7% 44
2016
Q1 		$40.9M Buy
632,314
+360,332
+132% +$23.9M 0.66% 46
2015
Q4 		$19.5M Buy
271,982
+82,224
+43% +$6.08M 0.35% 102
2015
Q3 		$14.6M Sell
189,758
-164,651
-46% -$13.3M 0.27% 141
2015
Q2 		$26.3M Sell
354,409
-2,741
-0.8% -$197K 0.47% 70
2015
Q1 		$25.9M Buy
357,150
+33,882
+10% +$2.36M 0.45% 76
2014
Q4 		$21.4M Buy
+323,268
New +$19.7M 0.41% 80
2014
Q1 		– Sell
-306,833
Closed -$16.4M – 672
2013
Q4 		$16.4M Sell
306,833
-158,327
-34% -$8.5M 0.38% 102
2013
Q3 		$23.4M Sell
465,160
-40,134
-8% -$1.96M 0.51% 64
2013
Q2 		$23.1M Buy
+505,294
New +$22.6M 0.5% 61

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PCP
P2 Capital Partners New York $246M AUM 17.67% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Thompson Siegel & Walmsley's MD Position: Q3 2019 in Review

Thompson Siegel & Walmsley sold out of Pediatrix Medical (MD) in Q3 2019, closing a stake of 241,813 shares — an estimated $6.1M sold.

Thompson Siegel & Walmsley first reported a position in MD in Q2 2013 and held it in 22 quarters. The position peaked at $131M in Q2 2017. 223 funds tracked by Wall St. Rank hold MD as of Q3 2019.

  • Thompson Siegel & Walmsley reported no remaining Pediatrix Medical position as of Q3 2019 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 241,813 Pediatrix Medical shares in Q3 2019, an estimated $6.1M.
  • Thompson Siegel & Walmsley first reported a position in Pediatrix Medical in Q2 2013 and held it in 22 quarters.
  • Thompson Siegel & Walmsley's Pediatrix Medical position peaked at $131M in Q2 2017.
  • 223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2019.

Based on Thompson Siegel & Walmsley's 13F filing for Q3 2019, filed 12 Nov 2019.